|
Novartis Institute for Tropical Diseases and Global Alliance for TB Drug Development
|
27 June 2008 |
|
Novartis reports higher sales and earnings in first quarter of 2008
|
24 April 2008 |
|
Novartis announces 20% average reduction in price of malaria drug Coartem®
|
24 April 2008 |
|
FTY720, a novel oral therapy in development for multiple sclerosis
|
21 April 2008 |
|
Patients with early Parkinson's disease show better symptom control
|
16 April 2008 |
|
Novartis to first acquire 25% stake from Nestlé for USD 143.18 per share for USD 11 billion
|
08 April 2008 |
|
Rasilez® reduces left ventricular hypertrophy, a powerful predictor of heart disease
|
01 April 2008 |
|
Femara® helps protect against return of breast cancer
|
12 March 2008 |
|
Novartis Vaccines Institute for Global Health (NVGH) is the first institute with nonprofit mission
|
25 February 2008 |
|
Novartis achieves record results in 2007 underscoring benefits of strategic healthcare portfolio
|
21 January 2008 |